These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 7858909)
21. Plasma carboxyl ester lipase activity modulates apolipoprotein B-containing lipoprotein metabolism in a transgenic mouse model. Li L; Weng W; Harrison EH; Fisher EA Metabolism; 2008 Oct; 57(10):1361-8. PubMed ID: 18803939 [TBL] [Abstract][Full Text] [Related]
22. Atherogenic hyperlipoproteinemia. The cellular and molecular biology of plasma lipoproteins altered by dietary fat and cholesterol. Mahley RW Med Clin North Am; 1982 Mar; 66(2):375-402. PubMed ID: 7040843 [TBL] [Abstract][Full Text] [Related]
23. Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoproteins, intermediate density lipoproteins, and low density lipoproteins. Beltz WF; Kesäniemi YA; Howard BV; Grundy SM J Clin Invest; 1985 Aug; 76(2):575-85. PubMed ID: 4031063 [TBL] [Abstract][Full Text] [Related]
24. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes. Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863 [TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375 [TBL] [Abstract][Full Text] [Related]
26. Immunoaffinity isolation of apolipoprotein E-containing lipoproteins. Gibson JC; Rubinstein A; Ngai N; Ginsberg HN; Le NA; Gordon RE; Goldberg IJ; Brown WV Biochim Biophys Acta; 1985 Jun; 835(1):113-23. PubMed ID: 3924105 [TBL] [Abstract][Full Text] [Related]
27. Hepatic and intestinal contribution of two forms of apolipoprotein B to plasma lipoprotein fractions in the rat. Sparks CE; Hnatiuk O; Marsh JB Can J Biochem; 1981 Aug; 59(8):693-9. PubMed ID: 7296351 [TBL] [Abstract][Full Text] [Related]
28. Metabolism and Modification of Apolipoprotein B-Containing Lipoproteins Involved in Dyslipidemia and Atherosclerosis. Morita SY Biol Pharm Bull; 2016; 39(1):1-24. PubMed ID: 26725424 [TBL] [Abstract][Full Text] [Related]
29. Lipoprotein abnormalities in hypertriglyceridemia: significance in atherosclerosis. Eisenberg S Am Heart J; 1987 Feb; 113(2 Pt 2):555-61. PubMed ID: 3544770 [No Abstract] [Full Text] [Related]
30. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review. Oscarsson J; Hurt-Camejo E Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250 [TBL] [Abstract][Full Text] [Related]
31. Early kinetic abnormalities of apoB-containing lipoproteins in insulin-resistant women with abdominal obesity. Pont F; Duvillard L; Florentin E; Gambert P; Vergès B Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1726-32. PubMed ID: 12377756 [TBL] [Abstract][Full Text] [Related]
32. Human plasma lipoproteins: biochemical and clinical aspects. Seidel D Ann Clin Biochem; 1982 Jul; 19 (Pt 4)():278-83. PubMed ID: 7125578 [No Abstract] [Full Text] [Related]
33. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans. Millar JS; Brousseau ME; Diffenderfer MR; Barrett PH; Welty FK; Faruqi A; Wolfe ML; Nartsupha C; Digenio AG; Mancuso JP; Dolnikowski GG; Schaefer EJ; Rader DJ Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1350-6. PubMed ID: 16574893 [TBL] [Abstract][Full Text] [Related]
34. Current concepts of the molecular structure and metabolism of human apolipoproteins and lipoproteins. Brewer HB Klin Wochenschr; 1981 Sep; 59(18):1023-35. PubMed ID: 7029129 [TBL] [Abstract][Full Text] [Related]
35. An emerging understanding of the interactions of plasma lipoproteins with the arterial wall that leads to the development of atherosclerosis. Beisiegel U; St Clair RW Curr Opin Lipidol; 1996 Oct; 7(5):265-8. PubMed ID: 8937514 [No Abstract] [Full Text] [Related]
36. The production and use of monoclonal antibodies to measure apolipoprotein B by a competitive enzyme-linked immunoassay. Waterson M; Samuel L; Miller E; Norman M Ann Clin Biochem; 1987 May; 24 ( Pt 3)():301-8. PubMed ID: 3111342 [TBL] [Abstract][Full Text] [Related]
37. Filtration of chylomicrons by the liver may influence cholesterol metabolism and atherosclerosis. Fraser R; Bosanquet AG; Day WA Atherosclerosis; 1978 Feb; 29(2):113-23. PubMed ID: 206268 [TBL] [Abstract][Full Text] [Related]
38. Lipoprotein physiology and its relationship to atherogenesis. Ginsberg HN Endocrinol Metab Clin North Am; 1990 Jun; 19(2):211-28. PubMed ID: 2192871 [TBL] [Abstract][Full Text] [Related]
40. Influence of obesity on the metabolism of apolipoprotein B in humans. Egusa G; Beltz WF; Grundy SM; Howard BV J Clin Invest; 1985 Aug; 76(2):596-603. PubMed ID: 4031064 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]